Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-09

FDA Approved: NIMODIPINE — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Camber Pharmaceuticals' original generic application for nimodipine, a calcium channel blocker used to reduce risk of cerebral vasospasm following …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nimodipine (Nimodipine)

Snippet

ORIG AP for NIMODIPINE (NIMODIPINE)